A double-blind, randomized, placebo-controlled, pilot study of topiramate vs. placebo in combination with olanzapine for the prevention of weight gain in manic or mixed youth with bipolar disorder
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2013
At a glance
- Drugs Topiramate (Primary) ; Olanzapine
- Indications Bipolar I disorders
- Focus Pharmacodynamics
- 20 Oct 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jul 2008 The expected completion date for this trial is now 1 Dec 2009 as reported by ClinicalTrials.gov.